Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06633926 · ClinicalTrials.gov registry record · NA

Integrative Approaches for Cancer Survivorship (IACS3)

A NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
108
Enrollment target
4
Study locations

NCT06633926 is a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 108 participants, below the 303-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (64% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06633926, a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
108 participants
Enrollment target
4
Study locations

Study Summary

This clinical trial is a two-arm pilot randomized controlled trial for non-metastatic breast cancer survivors to determine the feasibility, acceptability, and fidelity of two integrative health approaches and study design in a multi-site setting. Participants (n=104) will be randomized to either the Ayurveda Intervention (AVI) or Facing Forward Health Education Intervention (FFHEI). Integrative health combines biomedical and complementary approaches together in a coordinated way. AVI, a multi-modal intervention, includes nutritional education, lifestyle practices, yoga, and therapeutic touch, called marma, to help the body and mind feel balanced. FFHEI provides health education using self-directed online content and interactive videos based on the latest science in cancer survivorship. This study does not intend to conduct tests of efficacy and is focused on feasibility outcomes.

Interventions

  • OTHER Educational Intervention
  • OTHER Yoga
  • BEHAVIORAL Nutrition Education
  • BEHAVIORAL Lifestyle Counseling
  • PROCEDURE Marma therapy

Study Locations (4)

California

  • Zuckerberg San Francisco General - San Francisco
  • University of California, San Francisco - San Francisco
  • Kaiser Permanente Northwest (KPNW) - San Francisco

Tennessee

  • Vanderbilt Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2025-03-31
Est. Completion 2027-06-30
Phase NA

What the Registry Record Tells You About NCT06633926

The ClinicalTrials.gov registry entry for NCT06633926 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 303-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (64% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anatomic Stage III Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 5 interventions - of which Educational Intervention is the first listed.

NCT06633926 reports 4 study locations spanning 2 distinct geographic areas - top geographies include California, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06633926 about?

NCT06633926 is a clinical study titled "Integrative Approaches for Cancer Survivorship (IACS3)". This clinical trial is a two-arm pilot randomized controlled trial for non-metastatic breast cancer survivors to determine the feasibility, acceptability, and fidelity of two integrative health approaches and study design in a multi-site setting. Participants (n=104) will be randomized to either the...

What is the current status of trial NCT06633926?

This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2025-03-31. Estimated completion is 2027-06-30.

What conditions does trial NCT06633926 study?

This clinical trial studies the following conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8.

What interventions are being tested in trial NCT06633926?

The interventions under investigation include: Educational Intervention (OTHER), Yoga (OTHER), Nutrition Education (BEHAVIORAL), Lifestyle Counseling (BEHAVIORAL), Marma therapy (PROCEDURE).

Who is sponsoring clinical trial NCT06633926?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06633926 being conducted?

This trial has 4 study locations across California, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anatomic Stage III Breast Cancer AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.